全文获取类型
收费全文 | 82006篇 |
免费 | 11160篇 |
国内免费 | 531篇 |
专业分类
耳鼻咽喉 | 971篇 |
儿科学 | 2549篇 |
妇产科学 | 1952篇 |
基础医学 | 9351篇 |
口腔科学 | 2296篇 |
临床医学 | 13375篇 |
内科学 | 16784篇 |
皮肤病学 | 1754篇 |
神经病学 | 8202篇 |
特种医学 | 2368篇 |
外国民族医学 | 20篇 |
外科学 | 9291篇 |
综合类 | 1618篇 |
现状与发展 | 3篇 |
一般理论 | 47篇 |
预防医学 | 9502篇 |
眼科学 | 1499篇 |
药学 | 4891篇 |
5篇 | |
中国医学 | 640篇 |
肿瘤学 | 6579篇 |
出版年
2024年 | 208篇 |
2023年 | 1767篇 |
2022年 | 1099篇 |
2021年 | 2794篇 |
2020年 | 2399篇 |
2019年 | 2287篇 |
2018年 | 3579篇 |
2017年 | 3154篇 |
2016年 | 3253篇 |
2015年 | 3487篇 |
2014年 | 4272篇 |
2013年 | 5121篇 |
2012年 | 5455篇 |
2011年 | 5713篇 |
2010年 | 3916篇 |
2009年 | 3790篇 |
2008年 | 4432篇 |
2007年 | 4304篇 |
2006年 | 4148篇 |
2005年 | 3739篇 |
2004年 | 3311篇 |
2003年 | 2988篇 |
2002年 | 2908篇 |
2001年 | 1582篇 |
2000年 | 1391篇 |
1999年 | 1396篇 |
1998年 | 920篇 |
1997年 | 824篇 |
1996年 | 710篇 |
1995年 | 634篇 |
1994年 | 496篇 |
1993年 | 435篇 |
1992年 | 691篇 |
1991年 | 631篇 |
1990年 | 586篇 |
1989年 | 557篇 |
1988年 | 558篇 |
1987年 | 464篇 |
1986年 | 448篇 |
1985年 | 427篇 |
1984年 | 307篇 |
1983年 | 239篇 |
1982年 | 165篇 |
1981年 | 139篇 |
1979年 | 221篇 |
1978年 | 128篇 |
1977年 | 138篇 |
1976年 | 124篇 |
1974年 | 138篇 |
1972年 | 137篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
21.
22.
Emma J. Walker Noni E. MacDonald Nehal Islam Nicole Le Saux Karina A. Top Deshayne B. Fell 《Vaccine》2019,37(13):1725-1735
Objective
To systematically review literature on uptake and timeliness of diphtheria-tetanus-pertussis, measles-mumps-rubella, and/or polio-containing vaccines in infants who were born preterm, with a low birth weight, and/or with chronic health conditions that were diagnosed within the first 6?months of life.Methods
Using a standardized search strategy developed by a medical librarian, records were extracted from MEDLINE, Embase, Database of Abstracts of Reviews of Effects, and CINAHL up to May 8, 2018.Results
Out of the 1997 records that were screened, we identified 21 studies that met inclusion criteria. Eleven studies assessed vaccine coverage and/or timeliness in preterm infants, 6 in low birth weight infants, and 7 in children with chronic health conditions. Estimates of coverage in these populations were highly variable, ranging from 40% to 100% across the vaccines and population groups.Conclusions
There is a lack of studies reporting coverage and timeliness of routine immunizations in special populations of children.Policy implications
Our review suggests a need for improved surveillance of immunization status in special populations of infants, as well as a need for standardization of reporting practices. 相似文献23.
24.
25.
26.
27.
28.
It is hypothesized that persons who use drugs (PWUD) in Vietnam who are also HIV-positive may face additional challenges in psychosocial outcomes, and these challenges may extend to their family members. In this study, we examined depressive symptoms, stigma, social support, and caregiver burden of HIV-positive PWUD and their family members, compared to the outcomes of HIV-negative PWUD and their family members. Baseline, 3-month, and 6-month assessment data were gathered from 83 PWUD and 83 family members recruited from four communes in Phú Th? Province, Vietnam. For PWUD, although we observed a general decline in overall stigma over time for both groups, HIV-positive PWUD consistently reported significantly higher overall stigma for all three periods. Depressive symptoms among family members in both groups declined over time; however, family members of HIV-positive PWUD reported higher depressive symptoms across all three periods. In addition, family members of HIV-positive PWUD reported lower levels of tangible support across all three periods. Caregiver burden among family members of HIV-positive PWUD increased significantly over time, whereas the reported burden among family members of HIV-negative PWUD remained relatively unchanged. The findings highlight the need for future interventions for PWUD and family members, with targeted and culturally specific strategies to focus on the importance of addressing additional stigma experienced by PWUD who are HIV-positive. Such challenges may have direct negative impact on their family members' depressive symptoms, tangible support, and caregiver burden. 相似文献
29.
Flavia Temperilli Aldona Rina Isabella Massimi Anna Lisa Montemari Maria Luisa Guarino Alessandra Zicari 《Platelets》2015,26(8):783-787
Serum thromboxane-B2 (TxB2), together with arachidonic acid (AA)-induced platelet aggregation, are, at the moment, the most used tests to identify patients displaying high on-aspirin treatment platelet reactivity (HAPR). Both tests are specific for aspirin action on cyclooxygenase-1. While the correlation between serum TxB2 assay and clinical outcome is established, data are conflicting with regard to aspirin treatment and a possible association with AA-stimulated platelet markers and clinical outcome. To understand such discrepancy, we performed a retrospective study to compare both assays. We collected data from 132 patients receiving a daily dose of aspirin (100?mg/day) and data from 48 patients receiving aspirin on alternate days. All Patients who received a daily dose of aspirin were studied for AA-induced platelet aggregation together with serum TxB2 levels and AA-induced TxB2 formation was also studied in 71 patients out of entire population. Consistent with recommendations in the literature, we defined HAPR by setting a cut-off point at 3.1?ng/ml for serum levels of thromboxane B2 and 20% for AA-induced platelet aggregation. According to this cut-off point, we divided our overall population into two groups: (1) TxB2?<?3.1?ng/ml and (2) TxB2?>?3.1?ng/ml. We found low agreement between such tests to identify patients displaying HAPR. Our results show that AA-induced platelet aggregation >20% identify a smaller number of HAPR patients in comparison with TxB2. A good correlation between serum TxB2 and arachidonic acid-induced TxB2 production was found (r?=?0.76619). 相似文献